Global Biological Safety Testing Market 2017-2021: Growing Biotechnology & Pharmaceutical Industries Drive Growth - Research and Markets
Monday, 02 October 2017 02:06
Oct. 2, 2017 11:26 UTC

Global Biological Safety Testing Market 2017-2021: Growing Biotechnology & Pharmaceutical Industries Drive Growth - Research and Markets

DUBLIN--(BUSINESS WIRE)-- The "Global Biological Safety Testing Market 2017-2021" report has been added to Research and Markets' offering.

The global biological safety testing market is forecast to grow at a CAGR of 11.12% during the period 2017-2021.

The report, Global Biological Safety Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is International conferences promoting best practices of biosafety. There have been several collaborations to improve biosafety procedures and protocols. These collaborations organize annual events that discuss recent developments, discoveries, process improvement tools and techniques, and recommendations for industries. The oldest organization that promoted biosafety and improves protocols around the world is the ABSA. It was found in 1984 to promote biosafety as a scientific discipline and

address the growing needs of biosafety professionals across the world. It aims to provide a professional association that represents the interests and

Error. Page cannot be displayed. Please contact your service provider for more details. (7)

needs of the practitioners of biological safety.

One of the major drivers for this market is the growing biotechnology and pharmaceutical industries. Biological safety testing is essential to ensure the safety of finished products in the biotechnology and

pharmaceutical industries. Regulatory compliance and ensuring the production of products that are free from contaminations are essential for the success of pharmaceutical and biotechnology companies. Regulatory organizations require pharmaceutical products to comply with standard regulatory procedures. Due to the growing number of biopharmaceuticals, the demand for biological safety testing will increase during the forecast period. Therefore, the growth of the biotechnology and pharmaceutical industries will drive the growth of the global biological safety testing market.

Key vendors

  • Merck
  • Lonza
  • SGS
  • Thermo Fisher Scientific

Other prominent vendors

  • Air Science
  • Avance Biosciences
  • BSL Bioservice
  • Charles River Laboratories
  • Esco Micro
  • Nordic Scientific & Natural Solutions
  • NuAire
  • WuXi Biologics

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Segmentation By Offering

Part 07: Segmentation By Geography

Part 08: Decision Framework

Part 09: Drivers And Challenges

Part 10: Market Trends

Part 11: Vendor Landscape

Part 12: Key Vendor Analysis

Part 13: Appendix

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals

Source: Research and Markets

BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!